HOME > 発表論文集 > 学会発表 > Anti-Tumor Effect of Dendritic Cell-based Vaccine for Inoperable Prostatic Cancer.

発表論文集

Anti-Tumor Effect of Dendritic Cell-based Vaccine for Inoperable Prostatic Cancer.

2012/10/10

Abe H1, Akiyama S1, Zhang B.N2
1Kudan Clinic, Tokyo, Japan, 2Department of Immunology, Harbin Medical University
 

Abstract

Increase of prostatic cancer is now big social problem worldwide. 20 prostatic cancer patients with inoperable and castration resistant were treated with dendritic cell based vaccine pulsed with cancer associated peptide. Method was already reported in the previous International Symposium DC2010 at Lugano, Switzerland.
The results will be shown here. Overall survival of the 20 patients at 24 months was 60% and they keep the same level at 40 months.
Severe side effects of more than Grade 2 (CTCAE) were not observed. It was strongly suggested that DC vaccine pulsed with cancer associated antigen was safe and effective in the inoperable prostatic cancer patients with refractory to castration therapy.


 

The 12th International Symposium on Dendritic Cells

October 7-11, 2012 Exco Daegu, Korea



ページトップ

"
Copyright KUDAN